1. Home
  2. MRCY vs HAE Comparison

MRCY vs HAE Comparison

Compare MRCY & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

SELL

Current Price

$78.01

Market Cap

5.0B

Sector

N/A

ML Signal

SELL

HAE

Haemonetics Corporation

SELL

Current Price

$120.98

Market Cap

4.8B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MRCY
HAE
Founded
1981
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.8B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
MRCY
HAE
Price
$78.01
$120.98
Analyst Decision
Buy
Buy
Analyst Count
11
11
Target Price
$114.80
★ $122.20
AVG Volume (30 Days)
568.9K
★ 605.0K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.08
N/A
EPS
N/A
★ 0.72
Revenue
★ $983,622,000.00
$910,373,000.00
Revenue This Year
$10.46
$6.27
Revenue Next Year
$11.44
$5.86
P/E Ratio
★ N/A
$165.10
Revenue Growth
★ 7.85
N/A
52 Week Low
$65.04
$48.55
52 Week High
$128.45
$121.19

Technical Indicators

Market Signals
Indicator
MRCY
HAE
Relative Strength Index (RSI) 35.02 77.14
Support Level $73.38 $72.93
Resistance Level $89.06 N/A
Average True Range (ATR) 2.31 3.12
MACD 0.00 1.24
Stochastic Oscillator 7.71 98.90

Price Performance

Historical Comparison
MRCY
HAE

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: